Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Transjugular intrahepatic portosystemic stent-shunt does not reduce early graft survival in orthotopic liver transplantation

Transjugular intrahepatic portosystemic stent-shunt does not improve early graft function, or reduce peri-operative blood transfusion requirements, claims a report in this month's European Journal of Gastroenterology and Hepatology.

News image

fiogf49gjkf04

The transjugular intrahepatic portosystemic stent-shunt (TIPSS) is an expandable metal stent-shunt inserted between the hepatic and portal veins.

It was initially introduced to prevent variceal hemorrhage by producing a reduction in portal pressure.

In such cases insertion of a TIPSS has been shown to produce hemostasis in up to 80% of cases and a 75% 1-year survival rate.

Since then, its use has been extended to include management of diuretic resistant ascites and Type 1 hepatorenal syndrome, cirrhotic hydrothorax, Budd-Chiari syndrome and portal vein thrombosis.

In diuretic resistant or refractory ascites 75-90% of cases may lose ascites or become more diuretic sensitive following insertion of a TIPSS and renal function may improve significantly in patients with hepatorenal syndrome.

Patients with Budd-Chiari syndrome and cirrhosis with portal vein thrombosis may also demonstrate improvements in their clinical profile.

Many of these current indications for TIPSS use are also indications for consideration of orthotopic liver transplantation.

Reports in the literature have suggested that TIPSS insertion can reduce peri-operative transfusion times during orthotopic liver transplant.

This may result in fewer cases of poor, early graft function by reducing portosystemic shunting, leading to improved portal blood supply to the graft.

Researchers from the departments of Medicine and Radiology and the Scottish Liver Transplant Unit at the Royal Infirmary hospital in Edinburgh, UK, have therefore tested the hypotheses that TIPSS improves early graft function and reduces transfusion requirements.

They carried out a retrospective review of 82 liver transplant recipients between 1993 and 1999, with subgroups containing 29 patients who had TIPSS prior to first orthotopic liver transplant and 53 matched controls with TIPSS.

A longer hospital stay was required in the TIPSS patients
Eur J Gastroenterol Hepatol

No significant difference in the early graft function in the 2 groups was identified.

The prothrombin time before an orthotopic liver transplant was independently predictive of initial poor function.

Transfusion times and total operating times were similar for both groups, although transfusion requirements were greater in those patients where TIPSS led to technical difficulties during the operation (n = 6).

The TIPSS patients required a longer hospital stay than the non-TIPSS subjects (41 ± 8 versus 26 ± 4 days).

Pulmonary infection was found to be less common in the TIPSS group, who also experienced reduced wound infections.

The 12-month patient and graft survival rates in both groups were similar.

Serum albumin levels assessed before orthotopic liver transplant independently predicted 12-month graft survival.

Dr Dhiraj Tripathi, one of the researchers who carried out the study, said their findings showed that "TIPSS does not improve early graft function, nor reduce blood transfusion requirements peri-operatively."

"TIPSS prior to transplantation, despite having the potential for technical operative complications, has no detrimental effects on patient and graft survival, and if required should be undertaken."

He added, "The longer post-operative hospital stay in the TIPSS group is worthy of further study."

Eur J Gastroenterol Hepatol 2002; 14(8): 827-832
07 August 2002

Go to top of page Email this page Email this page to a colleague

 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Post‐operative complications in elderly IBD
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Esophageal dilatation in clinical practice 
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 30 April 2018 
Patient-reported outcome measures in IBD trials
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's
 24 April 2018 
Microbiome in athletes vs sedentary subjects
 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure
 23 April 2018 
Antibody suitable for further clinical development to complement existing therapeutic strategies for HCV
 23 April 2018 
Sleep deprivation and NAFLD in the USA

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us